強気
$9.29
シナリオ価格
$10.910
+0.050 (+0.46%)終値時点
Translational Development Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any specific business combination target, and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The Company has neither engaged in any operations nor generated any revenues.
TDAC is a good buy right now due to its recent merger with ProLogium, which has a pre-money valuation of $3.8 billion, indicating significant growth potential. The stock is currently priced at $10.83, which is 77.8% of its 52-week range, suggesting it is near its high. Additionally, the RSI is at 48.77, indicating it is not overbought, which is favorable for entry. However, the main risk is the current ratio of 0.06, indicating potential liquidity issues in the near term.
シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

ProLogium Appoints New Independent Director

ProLogium Advances Collaboration with Rimac on EV Battery Development

ProLogium Deepens Strategic Partnership with Kyushu Electric Power

ProLogium Appoints Rimac CEO to Board Amid Growth Phase

ProLogium Secures $50 Million Investment for Growth
Translational Development Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any specific business combination target, and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The Company has neither engaged in any operations nor generated any revenues. It operates in the Financials sector.
TDAC is a good buy right now due to its recent merger with ProLogium, which has a pre-money valuation of $3.8 billion, indicating significant growth potential. The stock is currently priced at $10.83, which is 77.8% of its 52-week range, suggesting it is near its high. Additionally, the RSI is at 48.77, indicating it is not overbought, which is favorable for entry. However, the main risk is the current ratio of 0.06, indicating potential liquidity issues in the near term.
投稿はまだありません
登録またはログインして議論に参加本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。